**
The alarming rise of individuals experiencing severe symptoms from topical steroid withdrawal (TSW) has come to the forefront of public health discussions, revealing a crisis that many medical professionals are yet to fully acknowledge. With growing numbers documenting their painful journeys on social media—most notably through the #TSW movement—patients like Bethany Gamble and Henry Jones are shedding light on a condition that remains largely misunderstood by the medical community.
A Sudden Shift in Health
Bethany Gamble’s battle with eczema began early in her childhood, managed effectively with steroid creams for over a decade. However, at the age of 18, her condition took a dramatic turn. “My skin was hot, so inflamed and red. It began to crack and ooze, and the itch was bone deep,” the 21-year-old from Birmingham recalls. The once manageable eczema spiralled into a debilitating condition, rendering her bedridden and reliant on her mother for care.
The most distressing aspect for Bethany was the dismissal of her suffering by health professionals. “I was constantly gaslit by doctors. They kept telling me it was just my eczema and offering me more steroids,” she asserts. What she and many others are experiencing is known as TSW, or red skin syndrome—an increasingly recognised but still under-researched reaction to the prolonged use of topical steroids.
The TSW Phenomenon
The emergence of TSW has sparked discussions among dermatologists and patients alike, yet there is a significant divide in understanding its nature. While some experts believe it is a severe adverse reaction to steroid creams—commonly prescribed to the eight million people in the UK suffering from eczema—others argue it is merely a flare-up of the original skin condition.
Professor Sara Brown, a consultant dermatologist at the University of Edinburgh, has noted unexplainable patterns among her patients. “We’re seeing symptoms like thickening and laxity of the skin, so-called ‘elephant skin’, extreme shedding, and sharply defined areas of redness next to normal skin,” she explains. Motivated by the urgent need for clarity, Professor Brown has secured funding to investigate TSW, recruiting hundreds of participants across the UK for her study.
Diverse Experiences and Challenges
Henry Jones, a 22-year-old from High Wycombe, is among those participating in this crucial research. Once able to manage his eczema with occasional steroid use, he found himself in a downward spiral, culminating in the need to abandon his university studies. “My GP kept telling me it was just eczema—something didn’t feel right,” he reflects.
Henry’s experience is emblematic of the widespread impact of TSW, which often goes unrecognised, particularly among individuals with darker skin tones, where symptoms may present differently. “TSW took everything away from me. I had to hide from the world for so long,” shares Karishma Leckraz, who spent years unaware of her TSW symptoms due to their distinct appearance on her skin.
The psychological toll of TSW cannot be overstated. Many patients experience crippling anxiety and social isolation, exacerbated by the challenges of obtaining a correct diagnosis. Waiting times for dermatological consultations can extend beyond a year, leaving patients in a state of limbo, often reliant on treatments that may not be effective.
The Need for Comprehensive Support
While topical steroids remain a cornerstone treatment for many skin conditions, the emergence of TSW has prompted calls for increased awareness and better support systems. Andrew Procter from the National Eczema Society acknowledges the dilemma faced by patients. “Patients are stuck between a rock and a hard place,” he states, recognising the efficacy of steroids for many while highlighting the fears surrounding TSW.
At the Royal London Hospital, dermatologist Dr Alia Ahmed runs a specialised clinic addressing chronic skin diseases. She emphasises the importance of a holistic approach to treatment, which encompasses both the physical and psychological aspects of skin conditions. “The psychological impact, as well as the physical effects, is huge,” she notes.
Despite the official recognition of TSW by the Medicines and Health Regulatory Authority (MHRA) in 2021, there is still a lack of widespread understanding among healthcare providers. This gap in knowledge can lead to misdiagnosis and inadequate treatment plans for those suffering from this debilitating condition.
A Long Road to Recovery
For many, the journey to recovery from TSW is fraught with challenges. Rebecca Ebbage, who stopped using topical steroids in July 2022, describes her skin as a “ruler” that dictates her daily life. After navigating through various treatments, including immunosuppressants and private therapies, she has begun to see improvement but stresses the importance of ongoing support.
As awareness grows, so too does the resilience of those affected by TSW. Karishma Leckraz, once overwhelmed by her skin’s appearance, has transformed her struggles into a platform for advocacy. “I’ve spoken to thousands of people about their skin condition,” she shares, determined to prevent others from enduring similar hardships.
Bethany’s story is one of hope; she has recently started biologic treatments aimed at addressing inflammation and has secured employment, feeling that she is finally regaining control over her life. Her message to others facing similar battles is clear: “Do not feel guilty, do not feel like it’s your fault—and fight to be believed.”
Why it Matters
The increasing visibility of TSW and the stories shared by those affected highlight an urgent need for research, awareness, and comprehensive care for skin conditions. The experiences of patients like Bethany, Henry, and Karishma underscore the complexities of managing eczema and the potential repercussions of treatment options. As the dialogue around TSW expands, it is imperative that healthcare professionals acknowledge these challenges, ensuring that patients receive the understanding and support they deserve.
